Purchase Order 75N92019P00319

Award Date 8/15/19
Potential Completion Date 8/14/21
Potential Value $86K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the National Heart, Lung and Blood Institute (NHLBI), a civilian agency of the U.S. government, to Astrix Technology LLC, a for-profit limited liability company. The contract is a delivery order valued at $118,386.85 and has an ultimate completion date of May 23, 2025. The purpose of the contract is to provide staffing for a clinical researcher to expand the research capacity in the lab, which will enable continued research in important areas of gene therapy for...
This is a $2,275,305.00 definitive cost-no-fee contract awarded by the U.S. Food and Drug Administration (FDA) to Children's Hospital Los Angeles (CHLA) with a performance period through June 16, 2024. The contract is for the development of a model that integrates inflammation and tissue injury to predict and mitigate the post-acute sequelae of COVID-19. As prime contractor, CHLA has subcontracted portions of the work to the University of Southern California and the University of California, Los...
The National Institutes of Health, National Heart Lung and Blood Institute awarded a firm fixed price purchase order valued at twelve thousand dollars to The Johns Hopkins University. Under this contract, the prime contractor will support the Fitzhugh Joseph Lab, Cardiovascular and Myeloproliferative Disorders Branch, Leukemia Section Myeloproliferative Neoplasms Program by conducting research to identify genetic risk factors for myeloid malignancy development after curative therapies for sickle...
The federal contract award is for research and development facilities with Children's Hospital Los Angeles (CHLA), doing business as Childrens Hospital LOS Angeles, as the prime contractor. The $21,453,351.79 cost-reimbursement contract was awarded on August 1, 2001 by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency. The contract has no set-aside designation and is set to expire on November 27, 2013. CHLA is a leading pediatric academic medical center...
This is a $4,945,536.05 definitive contract awarded by the National Heart, Lung, and Blood Institute (NHLBI) to New England Research Institutes Inc. (NERI) to continue the BABY HUG Follow-Up Study II. The contract is for a 12-month period starting January 1, 2016 to complete the final year of follow-up for the study, which is tracking long-term health outcomes for children with sickle cell disease who were previously enrolled in the BABY HUG clinical trial. NERI will be transitioning the study...
This is a $32,880.96 firm-fixed-price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Medical Science & Computing, LLC, a for-profit limited liability company. The contract provides a lab technician to support the maintenance of sample databases for the NHLBI Sickle Cell Branch. This is a Blanket Purchase Agreement (BPA) call order issued under the...
This is a $48,051,765.59 definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to the University of California, Los Angeles (UCLA) to provide biomedical research and related services. The contract has no set-aside designation and was awarded on September 22, 1994 with a completion date of June 20, 2014. As the prime contractor, UCLA's Office of Research Administration is leveraging the university's...
This is a federal contract award from the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services (HHS), to a small, woman-owned, minority-owned business named LI, Lina. The contract has a firm fixed price of $319,857.12 and an ultimate completion date of October 14, 2018. The contract was awarded on July 1, 2016 and was not set aside for any specific business type. Without additional details on the original solicitation, the specific...
This contract was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to Medical Science & Computing, LLC, a for-profit limited liability company. The contract, which has a ceiling value of $247,778.97, is a call order under the Multiple Award Schedule (MAS) program administered by the General Services Administration (GSA). The contract requires the contractor to provide a...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health (NIH) Clinical Center to Children's Hospital, a non-profit pediatric academic medical center, for patient hospitalization services. The contract has a potential value of $200,000.00 and a completion date of August 31, 2024. No set-aside designation was used. Children's Hospital has served as a prime contractor on numerous federal contracts with NIH and other agencies,...

This is a $85,687.25 firm fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services (HHS), to Children's Hospital Los Angeles (CHLA). The contract is for a research project titled "MYOCARDIAL DYSFUNCTION IN PATIENTS WITH SICKLE CELL DISEASE ASSESSED BY STRAIN ANALYSIS." This project is focused on evaluating cardiac dysfunction in patients with sickle cell disease using strain analysis techniques. The contract does not have a set-aside designation and was awarded on August 15, 2019, with a final completion date of August 14, 2021. CHLA is an experienced federal contractor and subcontractor, having previously collaborated on research projects with the Food and Drug Administration (FDA), National Cancer Institute (NCI), and various academic institutions funded by the National Institutes of Health (NIH) and Department of Defense.

Generated 6/8/24, 9:37 AM